NasdaqGM - Nasdaq Real Time Price USD
ArriVent BioPharma, Inc. (AVBP)
20.30
+0.95
+(4.92%)
As of 1:14:24 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 6 |
| Avg. Estimate | -0.72 | -0.8 | -4.18 | -3.61 |
| Low Estimate | -0.8 | -0.88 | -4.5 | -4.49 |
| High Estimate | -0.52 | -0.6 | -3.7 | -1.69 |
| Year Ago EPS | -0.65 | -0.61 | -2.56 | -4.18 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | 5.87M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 25.5M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.59 | -1.07 | -0.78 | -0.69 |
| EPS Actual | -0.65 | -0.61 | -0.61 | -1.9 |
| Difference | -0.06 | 0.46 | 0.17 | -1.21 |
| Surprise % | -10.47% | 42.83% | 21.93% | -175.36% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.72 | -0.8 | -4.18 | -3.61 |
| 7 Days Ago | -0.77 | -0.82 | -3.07 | -3.69 |
| 30 Days Ago | -0.77 | -0.82 | -3.07 | -3.69 |
| 60 Days Ago | -0.77 | -0.81 | -3.34 | -4.04 |
| 90 Days Ago | -0.84 | -0.88 | -3.49 | -4.25 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 2 | -- | -- |
| Down Last 7 Days | 2 | 2 | 4 | 2 |
| Down Last 30 Days | 2 | 2 | 4 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AVBP | -10.77% | -30.33% | -63.20% | 13.59% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Initiated | Jones Trading: Buy | 5/20/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/14/2025 |
| Initiated | B. Riley Securities: Buy | 3/20/2025 |
| Initiated | Guggenheim: Buy | 3/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
Related Tickers
MBX MBX Biosciences, Inc.
11.80
-2.88%
ORYZF Oryzon Genomics S.A.
3.0300
0.00%
DB0.F Q32 Bio Inc.
1.4900
-1.97%
2160.T GNI Group Ltd.
2,589.00
+0.12%
ORN.MU Oryzon Genomics SA
2.6200
0.00%
PHM.VI Pharma Mar, S.A.
83.05
+4.20%
0RC6.IL Pharma Mar, S.A.
82.95
+3.24%
CTNM Contineum Therapeutics, Inc.
3.9407
-9.82%
ORN.F Oryzon Genomics S.A.
2.5650
-1.91%
ARTV Artiva Biotherapeutics, Inc.
2.1500
+6.44%